Cerus (CERS) vs Orthofix Medical (OFIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cerus (CERS) has outperformed Orthofix Medical (OFIX) over the past year, gaining 43.1% versus a loss of 35.2%. Over five years, CERS leads with a -62.6% price change compared with -74.6% for OFIX. Cerus is the larger company by market cap ($446.4 million vs $360.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | OFIX |
|---|---|---|
| Share price | $2.22 | $8.91 |
| Market cap | $446.38M | $360.16M |
| 1-day change | -3.28% | -3.15% |
| YTD return | +11.17% | -39.31% |
| 1-year return | +43.13% | -35.21% |
| 5-year return | -62.58% | -74.61% |
| Forward P/E | — | 24.08 |
| EPS (TTM) | $-0.03 | $-1.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $16.99 |
| 52-week low | $1.38 | $8.50 |
| Distance from 52-week high | -36.17% | -47.56% |
| Analyst consensus | none | none |
| Avg. price target upside | +131.60% | +45.90% |
| Average volume | 2.13M | 364.58K |
| Shares outstanding | 201.52M | 40.42M |
| Employees | 261 | 1,605 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CERS has outperformed OFIX by 78.3 percentage points over the past year.
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Health Care · Medical/Dental Instruments · 261 employees
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
CERS vs OFIX FAQ
Which is bigger, Cerus or Orthofix Medical?
Cerus (CERS) is larger, with a market capitalization of $446.38M compared with $360.16M for Orthofix Medical (OFIX).
Which stock has performed better over the past year, CERS or OFIX?
CERS returned +43.13% over the past 12 months, compared with -35.21% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and Orthofix Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.